1. Home
  2. ELEV vs CJMB Comparison

ELEV vs CJMB Comparison

Compare ELEV & CJMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELEV
  • CJMB
  • Stock Information
  • Founded
  • ELEV 2019
  • CJMB 2007
  • Country
  • ELEV United States
  • CJMB United States
  • Employees
  • ELEV N/A
  • CJMB N/A
  • Industry
  • ELEV Biotechnology: Pharmaceutical Preparations
  • CJMB
  • Sector
  • ELEV Health Care
  • CJMB
  • Exchange
  • ELEV Nasdaq
  • CJMB NYSE
  • Market Cap
  • ELEV 20.0M
  • CJMB 18.2M
  • IPO Year
  • ELEV 2021
  • CJMB 2025
  • Fundamental
  • Price
  • ELEV $0.34
  • CJMB $5.04
  • Analyst Decision
  • ELEV Buy
  • CJMB
  • Analyst Count
  • ELEV 6
  • CJMB 0
  • Target Price
  • ELEV $2.94
  • CJMB N/A
  • AVG Volume (30 Days)
  • ELEV 975.2K
  • CJMB 29.5K
  • Earning Date
  • ELEV 05-23-2025
  • CJMB 01-01-0001
  • Dividend Yield
  • ELEV N/A
  • CJMB N/A
  • EPS Growth
  • ELEV N/A
  • CJMB N/A
  • EPS
  • ELEV N/A
  • CJMB N/A
  • Revenue
  • ELEV N/A
  • CJMB $6,563,412.00
  • Revenue This Year
  • ELEV N/A
  • CJMB N/A
  • Revenue Next Year
  • ELEV N/A
  • CJMB N/A
  • P/E Ratio
  • ELEV N/A
  • CJMB N/A
  • Revenue Growth
  • ELEV N/A
  • CJMB N/A
  • 52 Week Low
  • ELEV $0.22
  • CJMB $3.38
  • 52 Week High
  • ELEV $4.33
  • CJMB $7.76
  • Technical
  • Relative Strength Index (RSI)
  • ELEV 48.18
  • CJMB N/A
  • Support Level
  • ELEV $0.33
  • CJMB N/A
  • Resistance Level
  • ELEV $0.37
  • CJMB N/A
  • Average True Range (ATR)
  • ELEV 0.03
  • CJMB 0.00
  • MACD
  • ELEV 0.00
  • CJMB 0.00
  • Stochastic Oscillator
  • ELEV 25.54
  • CJMB 0.00

About ELEV Elevation Oncology Inc. Common stock

Elevation Oncology Inc is an oncology company focused on the development of selective cancer therapies to treat patients across a range of solid tumors with unmet medical needs. Its product candidate, EO-3021 (also known as SYSA1801 or CPO102), is an ADC comprised of a fully human anti-Claudin 18.2 immunoglobulin G1 (IgG1) monoclonal antibody (mAb) site-specifically conjugated with a cleavable linker to the cytotoxic monomethyl auristatin E (MMAE) payload. Claudin 18.2 is overexpressed in several types of cancers, including gastric, esophageal, pancreatic, ovarian and lungon.

About CJMB CALLAN JMB INC

Callan Jmb Inc is a vertically integrated logistics and fulfillment company that provides cryogenic logistics solutions to the life sciences industry through a combination of proprietary packaging, information technology, and specialized cold chain logistics know-how. It provides a system that utilizes predictive technology to revolutionize the supply chain by guaranteeing the safety, effectiveness, and potency of every product handled to ensure product integrity and to provide immediate response in industries while ensuring environmental responsibility. The company views its solutions as disruptive to the older technologies of dry ice and liquid nitrogen in that its solutions are comprehensive and combine its competencies in configurations that are customized to its clients.

Share on Social Networks: